News

pharmaceutical drug approval process

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 

Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

sleep bed insomnia awake

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep. 

Wegovy and happy people walking

The rise of these medications continues to be one of the biggest stories in healthcare.

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

In some cases, researchers noted, cardiologists may need to rely on transcaval access during the treatment of a high-risk heart failure patient. 

Tandem Mobi Insulin Pump

The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately. 

heart data research doctor cardiologist AI

Identifying the signs of severe aortic stenosis is typically a fairly straightforward process for cardiologists. In some cases, however, the patient’s symptoms present in a way that is outside of the norm. 

Thumbnail

A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.

Thumbnail

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic. 

A late-breakling study session at the 2022 Heart Rhythm DSociety (HRS) conference. Here is a list of all the late breaking studies at #HeartRhythm22

Heart Rhythm 2022, held from April 28 to May 1 in San Francisco, included a wide range of studies presented by some of the industry's leading specialists. 

Thumbnail

Although current guidelines recommend radiologists evaluate CAC on all non-gated, non-contrast chest CT scans, the authors of the study note that these guidelines are not consistently followed.

mavacamten

The FDA’s approval was based on data from the EXPLORER-HCM trial, which showed that mavacamten was superior to a placebo for treating obstructive HCM and associated with no significant long-term, treatment-related adverse events.

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.